Reviews Antihemophilic Factor


No reviews yet.

Alphanate Drug Description
ALPHANATE©
(antihemophilic factor) (HUMAN)
Solvent Detergent / Heat Treated
DRUG DESCRIPTION



What are the possible side effects of antihemophilic factor (factor VIII)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these serious side effects:

nausea, stomach pain, low fever, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes);
fever, chills, runny nose, and drowsiness followed about 2 weeks later by a rash and joint pain;
fast...
Read All Potential Side Effects for Alphanate »




Antihemophilic Factor (Human), Alphanate®, Solvent Detergent / Heat Treated, is a single dose, sterile, lyophilized concentrate of Factor VIII (AHF) intended for intravenous administration in the treatment of hemophilia A, or acquired Factor VIII deficiency.
Alphanate® is prepared from pooled human plasma by cryoprecipitation of
the Factor VIII, fractional solubilization, and further purification employing
heparin-coupled, cross-linked agarose which has an affinity to the heparin binding
domain of vWf/FVIII:C complex.1 The product is treated with a mixture
of tri(n-butyl) phosphate (TNBP) and polysorbate 80 to reduce the risks of transmission
of viral infection. In order to provide an additional safeguard against potential
non-lipid enveloped viral contaminants, the product is also subjected to a 80
°C heat treatment step for 72 hours. However, no procedure has been shown
to be totally effective in removing viral infectivity from coagulation factor
products.
Alphanate® is labeled with the antihemophilic factor potency (Factor VIIIC
activity) expressed in International Units (I U) per vial, which is referenced
to the WHO International Standard.
Alphanate® contains Albumin (Human) as a stabilizer, resulting in a final container concentrate with a specific activity of at least 5 IU FVIII:C/mg total protein. Prior to the addition of the Albumin (Human) stabilizer, the specific activity is significantly higher.
When reconstituted with the appropriate volume of Sterile Water for Injection,
USP, Alphanate® contains 0.3 - 0.9 g Albumin (Human)/100 mL; NMT 5 mmol
calcium/L; NMT 750 µg glycine/IU FVIIIC; NMT 1.0 U heparin/mL; 10 - 40
mmol histidine/L; NMT 0.1 mg imidazole/mL; 50 - 200 mmol arginine/L; NMT 1.0
µg polyethylene glycol and polysorbate 80/IU FVIII:C; NMT 10 mEq sodium/vial;
and NMT 0.1 µg TNBP/IU FVIIIC.
REFERENCES
1. Fujimura, Y., Titani, K., Holland, L.Z., Roberts, J.R.,
Kostel, P., Ruggeri, Z.M., Zimmerman, T.S. A Heparin-Binding Domain of Human
Von Willebrand Factor: Characterization and Localization to a Tryptic Fragment
Extending from Amino Acid Residue Val-449 to Lys-728. I Biol Chem 1987, 262(4):
1 734-1 739.Last reviewed on RxList: 11/14/2008




Alphanate Drug Description
ALPHANATE©
(antihemophilic factor) (HUMAN)
Solvent Detergent / Heat Treated
DRUG DESCRIPTION



What are the possible side effects of antihemophilic factor (factor VIII)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these serious side effects:

nausea, stomach pain, low fever, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes);
fever, chills, runny nose, and drowsiness followed about 2 weeks later by a rash and joint pain;
fast...
Read All Potential Side Effects for Alphanate »




Antihemophilic Factor (Human), Alphanate®, Solvent Detergent / Heat Treated, is a single dose, sterile, lyophilized concentrate of Factor VIII (AHF) intended for intravenous administration in the treatment of hemophilia A, or acquired Factor VIII deficiency.
Alphanate® is prepared from pooled human plasma by cryoprecipitation of
the Factor VIII, fractional solubilization, and further purification employing
heparin-coupled, cross-linked agarose which has an affinity to the heparin binding
domain of vWf/FVIII:C complex.1 The product is treated with a mixture
of tri(n-butyl) phosphate (TNBP) and polysorbate 80 to reduce the risks of transmission
of viral infection. In order to provide an additional safeguard against potential
non-lipid enveloped viral contaminants, the product is also subjected to a 80
°C heat treatment step for 72 hours. However, no procedure has been shown
to be totally effective in removing viral infectivity from coagulation factor
products.
Alphanate® is labeled with the antihemophilic factor potency (Factor VIIIC
activity) expressed in International Units (I U) per vial, which is referenced
to the WHO International Standard.
Alphanate® contains Albumin (Human) as a stabilizer, resulting in a final container concentrate with a specific activity of at least 5 IU FVIII:C/mg total protein. Prior to the addition of the Albumin (Human) stabilizer, the specific activity is significantly higher.
When reconstituted with the appropriate volume of Sterile Water for Injection,
USP, Alphanate® contains 0.3 - 0.9 g Albumin (Human)/100 mL; NMT 5 mmol
calcium/L; NMT 750 µg glycine/IU FVIIIC; NMT 1.0 U heparin/mL; 10 - 40
mmol histidine/L; NMT 0.1 mg imidazole/mL; 50 - 200 mmol arginine/L; NMT 1.0
µg polyethylene glycol and polysorbate 80/IU FVIII:C; NMT 10 mEq sodium/vial;
and NMT 0.1 µg TNBP/IU FVIIIC.
REFERENCES
1. Fujimura, Y., Titani, K., Holland, L.Z., Roberts, J.R.,
Kostel, P., Ruggeri, Z.M., Zimmerman, T.S. A Heparin-Binding Domain of Human
Von Willebrand Factor: Characterization and Localization to a Tryptic Fragment
Extending from Amino Acid Residue Val-449 to Lys-728. I Biol Chem 1987, 262(4):
1 734-1 739.Last reviewed on RxList: 11/14/2008




Alphanate Drug Description
ALPHANATE©
(antihemophilic factor) (HUMAN)
Solvent Detergent / Heat Treated
DRUG DESCRIPTION



What are the possible side effects of antihemophilic factor (factor VIII)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these serious side effects:

nausea, stomach pain, low fever, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes);
fever, chills, runny nose, and drowsiness followed about 2 weeks later by a rash and joint pain;
fast...
Read All Potential Side Effects for Alphanate »




Antihemophilic Factor (Human), Alphanate®, Solvent Detergent / Heat Treated, is a single dose, sterile, lyophilized concentrate of Factor VIII (AHF) intended for intravenous administration in the treatment of hemophilia A, or acquired Factor VIII deficiency.
Alphanate® is prepared from pooled human plasma by cryoprecipitation of
the Factor VIII, fractional solubilization, and further purification employing
heparin-coupled, cross-linked agarose which has an affinity to the heparin binding
domain of vWf/FVIII:C complex.1 The product is treated with a mixture
of tri(n-butyl) phosphate (TNBP) and polysorbate 80 to reduce the risks of transmission
of viral infection. In order to provide an additional safeguard against potential
non-lipid enveloped viral contaminants, the product is also subjected to a 80
°C heat treatment step for 72 hours. However, no procedure has been shown
to be totally effective in removing viral infectivity from coagulation factor
products.
Alphanate® is labeled with the antihemophilic factor potency (Factor VIIIC
activity) expressed in International Units (I U) per vial, which is referenced
to the WHO International Standard.
Alphanate® contains Albumin (Human) as a stabilizer, resulting in a final container concentrate with a specific activity of at least 5 IU FVIII:C/mg total protein. Prior to the addition of the Albumin (Human) stabilizer, the specific activity is significantly higher.
When reconstituted with the appropriate volume of Sterile Water for Injection,
USP, Alphanate® contains 0.3 - 0.9 g Albumin (Human)/100 mL; NMT 5 mmol
calcium/L; NMT 750 µg glycine/IU FVIIIC; NMT 1.0 U heparin/mL; 10 - 40
mmol histidine/L; NMT 0.1 mg imidazole/mL; 50 - 200 mmol arginine/L; NMT 1.0
µg polyethylene glycol and polysorbate 80/IU FVIII:C; NMT 10 mEq sodium/vial;
and NMT 0.1 µg TNBP/IU FVIIIC.
REFERENCES
1. Fujimura, Y., Titani, K., Holland, L.Z., Roberts, J.R.,
Kostel, P., Ruggeri, Z.M., Zimmerman, T.S. A Heparin-Binding Domain of Human
Von Willebrand Factor: Characterization and Localization to a Tryptic Fragment
Extending from Amino Acid Residue Val-449 to Lys-728. I Biol Chem 1987, 262(4):
1 734-1 739.Last reviewed on RxList: 11/14/2008




Alphanate Drug Description
ALPHANATE©
(antihemophilic factor) (HUMAN)
Solvent Detergent / Heat Treated
DRUG DESCRIPTION



What are the possible side effects of antihemophilic factor (factor VIII)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these serious side effects:

nausea, stomach pain, low fever, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes);
fever, chills, runny nose, and drowsiness followed about 2 weeks later by a rash and joint pain;
fast...
Read All Potential Side Effects for Alphanate »




Antihemophilic Factor (Human), Alphanate®, Solvent Detergent / Heat Treated, is a single dose, sterile, lyophilized concentrate of Factor VIII (AHF) intended for intravenous administration in the treatment of hemophilia A, or acquired Factor VIII deficiency.
Alphanate® is prepared from pooled human plasma by cryoprecipitation of
the Factor VIII, fractional solubilization, and further purification employing
heparin-coupled, cross-linked agarose which has an affinity to the heparin binding
domain of vWf/FVIII:C complex.1 The product is treated with a mixture
of tri(n-butyl) phosphate (TNBP) and polysorbate 80 to reduce the risks of transmission
of viral infection. In order to provide an additional safeguard against potential
non-lipid enveloped viral contaminants, the product is also subjected to a 80
°C heat treatment step for 72 hours. However, no procedure has been shown
to be totally effective in removing viral infectivity from coagulation factor
products.
Alphanate® is labeled with the antihemophilic factor potency (Factor VIIIC
activity) expressed in International Units (I U) per vial, which is referenced
to the WHO International Standard.
Alphanate® contains Albumin (Human) as a stabilizer, resulting in a final container concentrate with a specific activity of at least 5 IU FVIII:C/mg total protein. Prior to the addition of the Albumin (Human) stabilizer, the specific activity is significantly higher.
When reconstituted with the appropriate volume of Sterile Water for Injection,
USP, Alphanate® contains 0.3 - 0.9 g Albumin (Human)/100 mL; NMT 5 mmol
calcium/L; NMT 750 µg glycine/IU FVIIIC; NMT 1.0 U heparin/mL; 10 - 40
mmol histidine/L; NMT 0.1 mg imidazole/mL; 50 - 200 mmol arginine/L; NMT 1.0
µg polyethylene glycol and polysorbate 80/IU FVIII:C; NMT 10 mEq sodium/vial;
and NMT 0.1 µg TNBP/IU FVIIIC.
REFERENCES
1. Fujimura, Y., Titani, K., Holland, L.Z., Roberts, J.R.,
Kostel, P., Ruggeri, Z.M., Zimmerman, T.S. A Heparin-Binding Domain of Human
Von Willebrand Factor: Characterization and Localization to a Tryptic Fragment
Extending from Amino Acid Residue Val-449 to Lys-728. I Biol Chem 1987, 262(4):
1 734-1 739.Last reviewed on RxList: 11/14/2008




Alphanate Drug Description
ALPHANATE©
(antihemophilic factor) (HUMAN)
Solvent Detergent / Heat Treated
DRUG DESCRIPTION



What are the possible side effects of antihemophilic factor (factor VIII)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these serious side effects:

nausea, stomach pain, low fever, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes);
fever, chills, runny nose, and drowsiness followed about 2 weeks later by a rash and joint pain;
fast...
Read All Potential Side Effects for Alphanate »




Antihemophilic Factor (Human), Alphanate®, Solvent Detergent / Heat Treated, is a single dose, sterile, lyophilized concentrate of Factor VIII (AHF) intended for intravenous administration in the treatment of hemophilia A, or acquired Factor VIII deficiency.
Alphanate® is prepared from pooled human plasma by cryoprecipitation of
the Factor VIII, fractional solubilization, and further purification employing
heparin-coupled, cross-linked agarose which has an affinity to the heparin binding
domain of vWf/FVIII:C complex.1 The product is treated with a mixture
of tri(n-butyl) phosphate (TNBP) and polysorbate 80 to reduce the risks of transmission
of viral infection. In order to provide an additional safeguard against potential
non-lipid enveloped viral contaminants, the product is also subjected to a 80
°C heat treatment step for 72 hours. However, no procedure has been shown
to be totally effective in removing viral infectivity from coagulation factor
products.
Alphanate® is labeled with the antihemophilic factor potency (Factor VIIIC
activity) expressed in International Units (I U) per vial, which is referenced
to the WHO International Standard.
Alphanate® contains Albumin (Human) as a stabilizer, resulting in a final container concentrate with a specific activity of at least 5 IU FVIII:C/mg total protein. Prior to the addition of the Albumin (Human) stabilizer, the specific activity is significantly higher.
When reconstituted with the appropriate volume of Sterile Water for Injection,
USP, Alphanate® contains 0.3 - 0.9 g Albumin (Human)/100 mL; NMT 5 mmol
calcium/L; NMT 750 µg glycine/IU FVIIIC; NMT 1.0 U heparin/mL; 10 - 40
mmol histidine/L; NMT 0.1 mg imidazole/mL; 50 - 200 mmol arginine/L; NMT 1.0
µg polyethylene glycol and polysorbate 80/IU FVIII:C; NMT 10 mEq sodium/vial;
and NMT 0.1 µg TNBP/IU FVIIIC.
REFERENCES
1. Fujimura, Y., Titani, K., Holland, L.Z., Roberts, J.R.,
Kostel, P., Ruggeri, Z.M., Zimmerman, T.S. A Heparin-Binding Domain of Human
Von Willebrand Factor: Characterization and Localization to a Tryptic Fragment
Extending from Amino Acid Residue Val-449 to Lys-728. I Biol Chem 1987, 262(4):
1 734-1 739.Last reviewed on RxList: 11/14/2008





Other reviews about Antihemophilic Factor on wordpress

An Angels Needs Your Help...
  by angelneedshelp
I don't know how can I start. All I know is I want to help in my own little way. This is my first time to post a […]


CSL Behring Signs Agreements With Canadian Blood Services and Hema-Quebec to Supply Life-Saving Therapies
  by scidstuff
CSL Behring Signs Agreements With Canadian Blood Services and Hema-Quebec to Supply Life-Saving Therapies -Company Joins Supplier Base Offering Broad Array of Healthcare Products to Patients with Immune Deficiency and […]


Contracts Provide Canadians With Access And Choice To Critical Therapies For Hemophilia And Primary Immune Deficiency
  by scidstuff
Contracts Provide Canadians With Access And Choice To Critical Therapies For Hemophilia And Primary Immune Deficiency 03 Apr 2008 Baxter Corporation (Canada) is pleased to announce contracts […]


How Much Blood is Donated Each Year
  by aabbis
AABB estimates that eight million volunteers donate blood each year. According to the 2005 National Blood Collection and Utilization Report about 15 million units of whole blood and […]


D-Day (Day Cancer "disappears" from my body...)
  by lovelylogan
I know that I still have a few entries to do to catch me up to the actual surgery date, but as time progresses I feel like I […]


Helixate FS aprroved by FDA for routine prophylaxis in children with Hemophilia A
  by bleedingdisorder
CSL Behring announced聽this week聽that Helixate庐 FS, Antihemophilic Factor (Recombinant), has been approved by the U.S. Food and Drug Administration (FDA) for routine prophylaxis in children with hemophilia A […]


Coagulation
  by eymz
Coagulation is a complex process by which blood forms clots. It is an important part of hemostasis (the cessation of blood loss from a damaged vessel), wherein a […]


You Don't have to go to Haiti to Change a Life
  by autodealership
After deciding to write a blog about Haiti and how we should all think of making a financial donation if we haven鈥檛 already, I came across a lot […]


NCC and Pfizer Partner to Provide 10 Million Units of Hemophilia Medicines
  by bleedingdisorder
source: PR Newswire RALEIGH, N.C., Feb. 23 /PRNewswire-USNewswire/ -- The National Cancer Coalition (NCC) is pleased to announce its recent collaboration with Pfizer, Inc to provide hemophilia medicines to […]


Traveling Tips for People with Von Willebrand Disease (VWD)
  by khansaleem25
People with the bleeding disorder von Willebrand Disease (VWD) can travel wherever they please. […]



Other reviews about Antihemophilic Factor on web:

Factor VIII (FVIII) is an essential blood clotting factor also known as anti-hemophilic factor (AHF). In humans, Factor VIII is encoded by the F8 gene. Factor VIII - Wikipedia, the free encyclopedia


an脗路ti脗路he脗路mo脗路phil脗路ic factor (n t-h m-f l k, n t-) n. Abbr. AHF. A protein substance in blood plasma that participates in and is essential for the blood-clotting process. antihemophilic factor - definition of antihemophilic factor by the ...


Physician reviewed antihemophilic factor (human) patient information - includes antihemophilic factor description, dosage and directions. antihemophilic factor (human) medical facts from Drugs.com


Antihemophilic factor is a naturally occurring protein in the blood that helps blood to clot. A lack of antihemophilic factor VIII is the cause of hemophilia A. antihemophilic factor Information - Drugs and Treatments - MedHelp


Information for patients from the National Library of Medicine. Antihemophilic Factor (Human): MedlinePlus Drug Information


Antihemophilic Factor, AHF, Factor VIII injection To return to the main entry click here . What is antihemophilic factor injection? Antihemophilic Antihemophilic Factor, AHF, Factor VIII injection: Information ...


factor /fac脗路tor/ (fak脗麓ter) an agent or element that contributes to the production of a result. accelerator factor coagulation f. V. angiogenesis factor a substance that causes ... antihemophilic factor - definition of antihemophilic factor in the ...


Consumer information about the medication ANTIHEMOPHILIC FACTOR, RECOMBINANT - INJECTION (Bioclate, Helixate, Kogenate, Recombinate), includes side effects, drug interactions ... ANTIHEMOPHILIC FACTOR, RECOMBINANT - INJECTION (Bioclate, Helixate ...


factor VIII n antihemophilic factor [AHF], antihemophilic globulin, antihemophilic globulin A, antihemophilic factor A, plasma thromboplastin factor Factor VIII: Definition from Answers.com


Your doctor has ordered antihemophilic factor (recombinant) to help your blood to clot. The drug will be either injected directly into your vein or added to an intravenous fluid ... Antihemophilic Factor (Recombinant): MedlinePlus Drug Information





Featured Reviews

Reviews Hectorol Injection

Hectorol Injection Drug Description HECTOROL (doxercalciferol) Injection, Solution DRUG DESCRIPTION What are the possible side effects of doxercalciferol (Hectorol)? If you experience any of the following serious side effects,...
Read More  |  Review This
Reviews Rabavert

Rabavert Drug Description RabAvert™ Rabies Vaccine for Human Use DRUG DESCRIPTION What are the possible side effects of rabies vaccine (RabAvert)? Keep track of any and all side effects you have after receiving this vaccine....
Read More  |  Review This
Reviews Travatan

Travatan Drug Description Travatan (travoprost) Ophthalmic Solution 0.004% Sterile DRUG DESCRIPTION What are the possible side effects of travoprost ophthalmic (Travatan)? Get emergency medical help if you have any of these signs...
Read More  |  Review This
Reviews Azulfidine EN-Tabs

Azulfidine EN-Tabs Drug Description Azulfidine EN-tabs® (sulfasalazine) Delayed Release Tablets, USP Enteric-coated Tablets DRUG DESCRIPTION What are the possible side effects of sulfasalazine oral (Azulfidine, Azulfidine...
Read More  |  Review This
Reviews Zantac

Zantac Drug Description ZANTAC® 150 (ranitidine hydrochloride) Tablets, USP ZANTAC® 300 (ranitidine hydrochloride) Tablets, USP ZANTAC® 25 (ranitidine hydrochloride effervescent) EFFERdose® Tablets ZANTAC® ...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....